Mirae Asset Global Investments Co., Ltd. Zai Lab LTD Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,132,201 shares of ZLAB stock, worth $80.7 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,132,201
Previous 4,603
46221.99%
Holding current value
$80.7 Million
Previous $120,000
64114.17%
% of portfolio
0.21%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ZLAB
# of Institutions
175Shares Held
52.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$228 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$144 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$138 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$124 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$119 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.71B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...